Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation

被引:26
作者
Lee, Alisa B. [1 ]
Harker-Murray, Paul [2 ]
Ferrieri, Patricia [2 ]
Schleiss, Mark R. [2 ]
Tolar, Jakub [2 ]
机构
[1] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Med Ctr, Div Pediat Hematol Oncol Blood & Marrow Transplan, Minneapolis, MN 55455 USA
关键词
bone marrow; intrathecal; intraventricular; micrococcus; oncology;
D O I
10.1002/pbc.21286
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Opportunistic infections contribute to morbidity and mortality of patients Undergoing hematopoietic stein cell transplantation and treatment for malignancies. Rothia mucilaginosa, a gram-positive bacterium, is responsible for rare, but often fatal meningitis in severely immunocomprornised patients. We describe two cases of meningitis from discrete strains of R. mucilaginosa on Our pediatric bone marrow transplant unit, summarize the published cases of R. mucilaginosa meningitis in oncology and stein cell transplant patients, and provide updated recommendations regarding the use of antibiotic therapy in this patient population.
引用
收藏
页码:673 / 676
页数:4
相关论文
共 22 条
[11]  
GUERMAZI A, 1995, AM J NEURORADIOL, V16, P1331
[12]   COMPLICATIONS OF BACTEREMIA DUE TO STOMATOCOCCUS-MUCILAGINOSUS IN NEUTROPENIC CHILDREN [J].
HENWICK, S ;
KOEHLER, M ;
PATRICK, CC .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (04) :667-671
[13]   AMINOGLYCOSIDE THERAPY OF GRAM-NEGATIVE BACILLARY MENINGITIS [J].
KAISER, AB ;
MCGEE, ZA .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (24) :1215-1220
[14]   VANCOMYCIN ADMINISTRATION INTO THE CEREBROSPINAL-FLUID - A REVIEW [J].
LUER, MS ;
HATTON, J .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) :912-921
[15]   STOMATOCOCCUS-MUCILAGINOSUS - AN EMERGING PATHOGEN IN NEUTROPENIC PATIENTS [J].
MCWHINNEY, PHM ;
KIBBLER, CC ;
GILLESPIE, SH ;
PATEL, S ;
MORRISON, D ;
HOFFBRAND, AV ;
PRENTICE, HG .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (03) :641-646
[16]   Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone [J].
Park, MK ;
Khan, J ;
Stock, F ;
Lucey, DR .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :278-278
[17]   Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child [J].
Skogen, PG ;
Kolmannskog, S ;
Bergh, K .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) :39-42
[18]   STOMATOCOCCUS-MUCILAGINOSUS MENINGITIS IN A CHILD WITH LEUKEMIA [J].
SOUILLET, G ;
CHOMARAT, M ;
BARBE, G ;
BALOUCK, N ;
PLOTON, C ;
PHILIPPE, N .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :1045-1045
[19]  
VANTIEL FH, 1995, EUR J CLIN MICROBIOL, V14, P193
[20]   ANTIMICROBIAL SUSCEPTIBILITIES OF STOMATOCOCCUS-MUCILAGINOSUS AND OF MICROCOCCUS SPP [J].
VONEIFF, C ;
HERRMANN, M ;
PETERS, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :268-270